Evidence map›Paper›PMID 39881241›Full record

Observational studyBMC pregnancy and childbirth2025

AI-based analysis of fetal growth restriction in a prospective obstetric cohort quantifies compound risks for perinatal morbidity and mortality and identifies previously unrecognized high risk clinical scenarios.

Raquel M Zimmerman, Edgar J Hernandez, Mark Yandell, Martin Tristani-Firouzi, Robert M Silver, William Grobman, David Haas, George Saade, Jonathan Steller, Nathan R Blue

Abstract readObservational Study
In one paragraph

Observational study in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Raquel M ZimmermanDepartment of Biomedical Informatics, University of Utah Health, Salt Lake City, UT, USA.
Edgar J HernandezUtah Center for Genetic Discovery, Department of Human Genetics, University of Utah Health, Salt Lake City, UT, USA.
Mark YandellUtah Center for Genetic Discovery, Department of Human Genetics, University of Utah Health, Salt Lake City, UT, USA.
Martin Tristani-FirouziDepartment of Pediatrics, Division of Pediatric Cardiology, University of Utah Health, Salt Lake City, UT, USA.
Robert M SilverDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Utah Health, 30 N. Mario Capecchi Dr., Level 5 South, Salt Lake City, UT, 84132, USA.
William GrobmanDepartment of Obstetrics and Gynecology, Warren Alpert Medical School, Brown University, Providence, RI, USA.
David HaasDepartment of Obstetrics and Gynecology, Indiana University, Indianapolis, IN, USA.
George SaadeDepartment of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA, USA.
Jonathan StellerDepartment of Obstetrics & Gynecology, Division of Maternal Fetal Medicine, University of California, Irvine, Orange, CA, USA.
Nathan R BlueDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Utah Health, 30 N. Mario Capecchi Dr., Level 5 South, Salt Lake City, UT, 84132, USA. nblue1297@gmail.com.

Funding

CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
Utah Women's Reproductive Health Research Career Development ProgramK12HD085816 · NICHD · UNIVERSITY OF UTAH · PI SILVER, ROBERT M. · 2015 to 2024
$3.2M
Preterm Birth in Nulliparous Women: An Understudied Population at Great RiskU10HD063053 · NICHD · UNIVERSITY OF UTAH · PI SILVER, ROBERT M. · 2010 to 2014
$1.7M
Preterm Birth in Nulliparous Women: An Understudied Population at Great Risk U10HD063020 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GROBMAN, WILLIAM ADAM · 2010 to 2014
$1.6M
Preterm Birth in Nulliparous Women: An Understudied Population at Great RiskU10HD063041 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI SIMHAN, HYAGRIV N · 2010 to 2014
$1.5M
Individualization of Fetal Growth Assessment using Maternal Genetics and Explainable AIK08HD113835 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Nathan Richard Blue · 2024 to 2026
$473k
Eunice Kennedy Shriver National Institute of Child Health and Human Development 2K12 HD085816-07NCATS NIH HHS UM1 TR004409NICHD NIH HHS K08 HD113835NICHD NIH HHS K12 HD085816NICHD NIH HHS U10 HD063020NICHD NIH HHS U10 HD063041NICHD NIH HHS U10 HD063053
6 · The paper itself

Abstract

backgroundFetal growth restriction (FGR) is a leading risk factor for stillbirth, yet the diagnosis of FGR confers considerable prognostic uncertainty, as most infants with FGR do not experience any morbidity. Our objective was to use data from a large, deeply phenotyped observational obstetric cohort to develop a probabilistic graphical model (PGM), a type of "explainable artificial intelligence (AI)", as a potential framework to better understand how interrelated variables contribute to perinatal morbidity risk in FGR.

methodsUsing data from 9,558 pregnancies delivered at ≥ 20 weeks with available outcome data, we derived and validated a PGM using randomly selected sub-cohorts of 80% (n = 7645) and 20% (n = 1,912), respectively, to discriminate cases of FGR resulting in composite perinatal morbidity from those that did not. We also sought to identify context-specific risk relationships among inter-related variables in FGR. Performance was assessed as area under the receiver-operating characteristics curve (AUC).

resultsFeature selection identified the 16 most informative variables, which yielded a PGM with good overall performance in the validation cohort (AUC 0.83, 95% CI 0.79-0.87), including among "N of 1" unique scenarios (AUC 0.81, 0.72-0.90). Using the PGM, we identified FGR scenarios with a risk of perinatal morbidity no different from that of the cohort background (e.g. female fetus, estimated fetal weight (EFW) 3-9th percentile, no preexisting diabetes, no progesterone use; RR 0.9, 95% CI 0.7-1.1) alongside others that conferred a nearly 10-fold higher risk (female fetus, EFW 3-9th percentile, maternal preexisting diabetes, progesterone use; RR 9.8, 7.5-11.6). This led to the recognition of a PGM-identified latent interaction of fetal sex with preexisting diabetes, wherein the typical protective effect of female fetal sex was reversed in the presence of maternal diabetes.

conclusionsPGMs are able to capture and quantify context-specific risk relationships in FGR and identify latent variable interactions that are associated with large differences in risk. FGR scenarios that are separated by nearly 10-fold perinatal morbidity risk would be managed similarly under current FGR clinical guidelines, highlighting the need for more precise approaches to risk estimation in FGR.

Indexed as

Artificial IntelligenceFetal Growth RetardationAdultFemaleHumansInfant, NewbornModels, StatisticalPerinatal MortalityPregnancyProspective StudiesRisk AssessmentRisk FactorsStillbirthExplainable artificial intelligenceFetal growth restrictionPerinatal morbidityPregnancyStillbirth

Identifiers

PMID39881241
PMCPMC11780823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.